Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1542/peds.2020-003186 http://scihub22266oqcxt.onion/10.1542/peds.2020-003186 32680880!7546093!32680880     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pediatrics 2020 ; 146 (4): ä Nephropedia Template TP {{tp|p=32680880|t=2020. Early Experience of COVID-19 in a US Children s Hospital |pdf=|usr=}}{{32680880}} gab.com Text Early Experience of COVID-19 in a US Children s Hospital JO: Pediatrics http://www.kidney.de/pget.php?&tw=1&pmid=32680880 #FOAvip OBJECTIVES: We aim to describe the demographics, clinical presentation, hospital course, and severity of pediatric inpatients with coronavirus disease 2019 (COVID-19), with an emphasis on healthy, immunocompromised, and chronically ill children. METHODS: We conducted a single-center retrospective cohort study of hospitalized children aged younger than 22 years with COVID-19 infection at Steven and Alexandra Cohen Children's Medical Center at Northwell Health. Cases were identified from patients with fever and/or respiratory symptoms who underwent a nucleic acid amplification-based test for severe acute respiratory syndrome coronavirus 2. RESULTS: Sixty-five patients were identified. The median age was 10.3 years (interquartile range, 1.4 months to 16.3 years), with 48% of patients older than 12 years and 29% of patients younger than 60 days of age. Fever was present in 86% of patients, lower respiratory symptoms or signs in 60%, and gastrointestinal symptoms in 62%. Thirty-five percent of patients required ICU care. The white blood cell count was elevated in severe disease (P = .0027), as was the C-reactive protein level (P = .0192), compared with mild and moderate disease. Respiratory support was required in 34% of patients. Severity was lowest in infants younger than 60 days of age and highest in chronically ill children; 79% of immunocompromised children had mild disease. One death was reported. CONCLUSIONS: Among children who are hospitalized for COVID-19, most are younger than 60 days or older than 12 years of age. Children may have severe infection requiring intensive care support. The clinical course of immunocompromised patients was not more severe than that of other children. Elevated white blood cell count and C-reactive protein level are associated with greater illness severity. Twit Text FOAVip Early Experience of COVID-19 in a US Children s Hospital ????Pediatrics http://www.kidney.de/pget.php?&tw=1&pmid=32680880 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32680880 #FOAvip English Wikipedia <ref>{{Cite pmid|32680880}}</ref> Early Experience of COVID-19 in a US Children s Hospital #MMPMID32680880 Kainth MK; Goenka PK; Williamson KA; Fishbein JS; Subramony A; Barone S; Belfer JA; Feld LM; Krief WI; Palumbo N; Rajan S; Rocker J; Scotto T; Sharma S; Sokoloff WC; Schleien C; Rubin LG Pediatrics 2020[Oct]; 146 (4): ä PMID32680880show ga OBJECTIVES: We aim to describe the demographics, clinical presentation, hospital course, and severity of pediatric inpatients with coronavirus disease 2019 (COVID-19), with an emphasis on healthy, immunocompromised, and chronically ill children. METHODS: We conducted a single-center retrospective cohort study of hospitalized children aged younger than 22 years with COVID-19 infection at Steven and Alexandra Cohen Children's Medical Center at Northwell Health. Cases were identified from patients with fever and/or respiratory symptoms who underwent a nucleic acid amplification-based test for severe acute respiratory syndrome coronavirus 2. RESULTS: Sixty-five patients were identified. The median age was 10.3 years (interquartile range, 1.4 months to 16.3 years), with 48% of patients older than 12 years and 29% of patients younger than 60 days of age. Fever was present in 86% of patients, lower respiratory symptoms or signs in 60%, and gastrointestinal symptoms in 62%. Thirty-five percent of patients required ICU care. The white blood cell count was elevated in severe disease (P = .0027), as was the C-reactive protein level (P = .0192), compared with mild and moderate disease. Respiratory support was required in 34% of patients. Severity was lowest in infants younger than 60 days of age and highest in chronically ill children; 79% of immunocompromised children had mild disease. One death was reported. CONCLUSIONS: Among children who are hospitalized for COVID-19, most are younger than 60 days or older than 12 years of age. Children may have severe infection requiring intensive care support. The clinical course of immunocompromised patients was not more severe than that of other children. Elevated white blood cell count and C-reactive protein level are associated with greater illness severity. |*Hospitals, Pediatric[MESH] |Adolescent[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Child[MESH] |Child, Preschool[MESH] |Chronic Disease[MESH] |Clinical Laboratory Techniques[MESH] |Coronavirus Infections/complications/diagnosis/immunology/*therapy[MESH] |Female[MESH] |Humans[MESH] |Immunocompromised Host[MESH] |Infant[MESH] |Length of Stay[MESH] |Male[MESH] |New York City[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/diagnosis/immunology/*therapy[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH]Early Experience of COVID-19 in a US Children s Hospital (epmc).pdf DeepDyve Pubget Overpricing